Surgery and uncontrolled chronic rhinosinusitis
- PMID: 35012709
- DOI: 10.1016/S2213-2600(21)00490-2
Surgery and uncontrolled chronic rhinosinusitis
Conflict of interest statement
I am a member of advisory boards for Sanofi, GSK, and AstraZeneca, and have received speaker fees from Olympus, Intersect, and Meda.
Comment on
-
Endoscopic sinus surgery with medical therapy versus medical therapy for chronic rhinosinusitis with nasal polyps: a multicentre, randomised, controlled trial.Lancet Respir Med. 2022 Apr;10(4):337-346. doi: 10.1016/S2213-2600(21)00457-4. Epub 2022 Jan 7. Lancet Respir Med. 2022. PMID: 35012708 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
